Literature DB >> 6324976

Effect of experimental diabetes on isolated rat heart responsiveness to isoproterenol.

R V Vadlamudi, J H McNeill.   

Abstract

The isolated perfused working rat heart was used to study experimental diabetes-induced alterations in the sensitivity and responsiveness of the myocardium to the effects of isoproterenol. Experimental diabetes was induced by intravenous administration of either 65 mg/kg alloxan or 60 mg/kg streptozotocin. The positive inotropic and cardiac relaxant effects of isoproterenol were studied at various time points after the induction of diabetes. There were no changes either in the sensitivity or in the maximum responses of diabetic rat hearts to the positive inotropic effect of isoproterenol at any time point studied. However, the cardiac relaxant effect of isoproterenol was depressed in acute as well as chronic diabetic rat hearts when compared with age-matched controls. Ventricular noradrenaline content was unchanged in 180-day diabetic rat hearts indicating the absence of a diabetes-induced sympathetic neuropathy in the heart. The depressed relaxing effect of isoproterenol may have resulted from alterations in energy utilization and sarcoplasmic reticular function in diabetic rat hearts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324976     DOI: 10.1139/y84-020

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  10 in total

Review 1.  Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.

Authors:  Reza Badalzadeh; Behnaz Mokhtari; Raana Yavari
Journal:  J Physiol Sci       Date:  2015-03-01       Impact factor: 2.781

2.  Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze.

Authors:  Vijay Sharma; John H McNeill
Journal:  World J Cardiol       Date:  2011-09-26

3.  Alterations in atrial reactivity in a strain of spontaneously diabetic rats.

Authors:  W Durante; F A Sunahara; A K Sen
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

Review 4.  Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors.

Authors:  Qin Fu; Qian Shi; Toni M West; Yang K Xiang
Journal:  J Cardiovasc Pharmacol       Date:  2017-08       Impact factor: 3.105

5.  Altered cardiac adrenergic neurotransmission in streptozotocin-induced diabetic rats.

Authors:  S Gando; Y Hattori; M Kanno
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 6.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

7.  Inhibition of nitric oxide synthase enhances contractile response of ventricular myocytes from streptozotocin-diabetic rats.

Authors:  Jacquelyn M Smith; Korie B Sondgeroth; Gordon M Wahler
Journal:  Mol Cell Biochem       Date:  2007-01-16       Impact factor: 3.842

8.  High-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of β2 -adrenergic receptor and impairs cardiac adrenergic reserve in animal hearts.

Authors:  Qin Fu; Yuting Hu; Qingtong Wang; Yongming Liu; Ning Li; Bing Xu; Sungjin Kim; Nipavan Chiamvimonvat; Yang K Xiang
Journal:  J Physiol       Date:  2017-02-02       Impact factor: 5.182

Review 9.  Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart.

Authors:  Betul R Erdogan; Martin C Michel; Ebru Arioglu-Inan
Journal:  Cells       Date:  2020-11-26       Impact factor: 6.600

Review 10.  The influence of diabetes on cardiac beta-adrenoceptor subtypes.

Authors:  V Melih Altan; Ebru Arioglu; Sahika Guner; A Tanju Ozcelikay
Journal:  Heart Fail Rev       Date:  2007-03-16       Impact factor: 4.654

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.